CHI3L1 in Multiple Sclerosis—From Bench to Clinic
Author Information
Author(s): Jatczak-Pawlik Izabela, Jurewicz Anna, Domowicz Małgorzata, Ewiak-Paszyńska Alicja, Stasiołek Mariusz
Primary Institution: Department of Neurology, Medical University of Lodz, Poland
Hypothesis
CHI3L1 may serve as a biomarker for the diagnosis and progression of multiple sclerosis.
Conclusion
CHI3L1 levels in cerebrospinal fluid and serum are associated with disease activity and may help in monitoring multiple sclerosis progression.
Supporting Evidence
- CHI3L1 levels in cerebrospinal fluid correlate with disease activity in multiple sclerosis.
- Elevated CHI3L1 levels may predict conversion from clinically isolated syndrome to clinically definite multiple sclerosis.
- CHI3L1 is produced by astrocytes and macrophages in active multiple sclerosis lesions.
- CHI3L1 is involved in neuroinflammation and may reflect ongoing glial activation.
Takeaway
CHI3L1 is a protein that can help doctors understand how severe multiple sclerosis is and how it might change over time.
Methodology
The review discusses the role of CHI3L1 in multiple sclerosis based on existing literature and studies.
Limitations
CHI3L1 is not specific to multiple sclerosis and can be elevated in other inflammatory conditions.
Participant Demographics
Multiple sclerosis patients, primarily young adults with a female predominance.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website